Sompo Japan Nipponkoa Asset Management CO. LTD. grew its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 12.2% during the third quarter, HoldingsChannel.com reports. The firm owned 107,790 shares of the pharmacy operator’s stock after buying an additional 11,740 shares during the period. Walgreens Boots Alliance makes up about 1.6% of Sompo Japan Nipponkoa Asset Management CO. LTD.’s holdings, making the stock its 21st biggest holding. Sompo Japan Nipponkoa Asset Management CO. LTD.’s holdings in Walgreens Boots Alliance were worth $7,858,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Cadence Bank NA grew its holdings in shares of Walgreens Boots Alliance by 5.3% in the 3rd quarter. Cadence Bank NA now owns 31,589 shares of the pharmacy operator’s stock valued at $2,303,000 after acquiring an additional 1,579 shares in the last quarter. O Shaughnessy Asset Management LLC grew its holdings in Walgreens Boots Alliance by 54.3% during the third quarter. O Shaughnessy Asset Management LLC now owns 328,178 shares of the pharmacy operator’s stock worth $23,839,000 after purchasing an additional 115,452 shares during the period. Summit Asset Management LLC grew its holdings in Walgreens Boots Alliance by 9.0% during the third quarter. Summit Asset Management LLC now owns 8,976 shares of the pharmacy operator’s stock worth $654,000 after purchasing an additional 741 shares during the period. Meyer Handelman Co. grew its holdings in Walgreens Boots Alliance by 17.9% during the third quarter. Meyer Handelman Co. now owns 124,300 shares of the pharmacy operator’s stock worth $9,061,000 after purchasing an additional 18,850 shares during the period. Finally, Fulcrum Capital LLC bought a new position in Walgreens Boots Alliance during the third quarter worth about $328,000. 64.57% of the stock is currently owned by institutional investors.

Shares of WBA stock opened at $82.39 on Friday. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.82 and a quick ratio of 0.38. The company has a market cap of $77.75 billion, a price-to-earnings ratio of 13.61, a P/E/G ratio of 1.30 and a beta of 0.74. Walgreens Boots Alliance Inc has a 12-month low of $59.07 and a 12-month high of $83.00.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.45 by $0.03. The firm had revenue of $33.44 billion during the quarter, compared to the consensus estimate of $33.64 billion. Walgreens Boots Alliance had a net margin of 3.82% and a return on equity of 21.75%. On average, sell-side analysts anticipate that Walgreens Boots Alliance Inc will post 6.54 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 12th. Stockholders of record on Monday, November 12th will be given a $0.44 dividend. The ex-dividend date is Thursday, November 8th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.14%. Walgreens Boots Alliance’s payout ratio is 29.24%.

In other news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, November 1st. The shares were sold at an average price of $79.48, for a total value of $217,457.28. Following the completion of the sale, the director now directly owns 8,207 shares in the company, valued at $652,292.36. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Kathleen Wilson-Thompson sold 52,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Wednesday, October 31st. The shares were sold at an average price of $78.77, for a total transaction of $4,096,040.00. Following the completion of the sale, the executive vice president now owns 81,076 shares of the company’s stock, valued at $6,386,356.52. The disclosure for this sale can be found here. Over the last quarter, insiders sold 66,706 shares of company stock valued at $5,268,584. 14.80% of the stock is owned by company insiders.

A number of equities analysts recently commented on the company. Pivotal Research lifted their price target on Walgreens Boots Alliance from $60.00 to $72.00 and gave the stock a “hold” rating in a report on Monday, October 15th. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $79.00 price target for the company in a report on Saturday, October 13th. Barclays lifted their price target on Walgreens Boots Alliance from $77.00 to $80.00 and gave the stock an “equal weight” rating in a report on Friday, October 12th. Robert W. Baird lifted their price target on Walgreens Boots Alliance from $69.00 to $71.00 and gave the stock a “neutral” rating in a report on Friday, October 12th. Finally, Citigroup lifted their price target on Walgreens Boots Alliance from $69.00 to $76.00 and gave the stock a “neutral” rating in a report on Friday, October 12th. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $78.22.

TRADEMARK VIOLATION WARNING: This piece of content was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of international trademark & copyright laws. The original version of this piece of content can be accessed at https://theolympiareport.com/2018/11/10/sompo-japan-nipponkoa-asset-management-co-ltd-has-7-86-million-stake-in-walgreens-boots-alliance-inc-wba.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Featured Story: Should you buy a closed-end mutual fund?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.